Cargando…
Corticosteroid Treatment-Resistance in Myasthenia Gravis
Chronic, high-dose, oral prednisone has been the mainstay of myasthenia gravis treatment for decades and has proven to be highly beneficial in many, toxic in some way to all, and not effective in a significant minority. No patient characteristics or biomarkers are predictive of treatment response le...
Autores principales: | Kaminski, Henry J., Denk, Jordan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083070/ https://www.ncbi.nlm.nih.gov/pubmed/35547366 http://dx.doi.org/10.3389/fneur.2022.886625 |
Ejemplares similares
-
Novel Treatments in Myasthenia Gravis
por: Menon, Deepak, et al.
Publicado: (2020) -
Rituximab treatment in myasthenia gravis
por: Vesperinas-Castro, Ana, et al.
Publicado: (2023) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
Treatment of insomnia in myasthenia gravis—A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia
por: Yan, Jingwen, et al.
Publicado: (2023) -
Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis
por: Duan, Weiwei, et al.
Publicado: (2022)